Daiana Stolz

Research interests

Publications

• COPD and multimorbidity: recognising and addressing a syndemic occurrence

  The Lancet Respiratory Medicine · 2023 · 10.1016/s2213-2600(23)00261-8

• Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease

  International Journal of Molecular Sciences · 2023 · 10.3390/ijms24043786

• Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

  The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)01273-9

• Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial

  The Lancet Respiratory Medicine · 2022 · 10.1016/s2213-2600(22)00086-8

• Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline

  European Respiratory Journal · 2021 · 10.1183/13993003.00048-2021

• Biomarkers in Pneumonia—Beyond Procalcitonin

  International Journal of Molecular Sciences · 2019 · 10.3390/ijms20082004

• Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections

  Cochrane Database of Systematic Reviews · 2017 · https://doi.org/10.1002/14651858.cd007498.pub3

• Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis

  The Lancet Infectious Diseases · 2017 · 10.1016/s1473-3099(17)30592-3

• Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis

  Clinical Infectious Diseases · 2012 · 10.1093/cid/cis464

• Propofolversuscombined sedation in flexible bronchoscopy: a randomised non-inferiority trial

  European Respiratory Journal · 2009 · 10.1183/09031936.00180808

• Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study

  European Respiratory Journal · 2009 · 10.1183/09031936.00053209

• Use of B-Type Natriuretic Peptide in the Risk Stratification of Acute Exacerbations of COPD

  CHEST Journal · 2008 · 10.1378/chest.07-1959

• A randomised, controlled trial of bosentan in severe COPD

  European Respiratory Journal · 2008 · 10.1183/09031936.00011308

• Antibiotic Treatment of Exacerbations of COPD

  CHEST Journal · 2007 · 10.1378/chest.06-1500

• Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia

  BMC Infectious Diseases · 2007 · 10.1186/1471-2334-7-10

• Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia

  American Journal of Respiratory and Critical Care Medicine · 2007 · 10.1164/rccm.200702-307oc

• Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD

  CHEST Journal · 2007 · 10.1378/chest.06-2336

• Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections

  European Journal of Clinical Investigation · 2007 · 10.1111/j.1365-2362.2007.01762.x

• Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]

  Critical Care · 2006 · 10.1186/cc4955

• Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

  American Journal of Respiratory and Critical Care Medicine · 2006 · https://doi.org/10.1164/rccm.200512-1922oc

• Cough suppression during flexible bronchoscopy using combined sedation with midazolam and hydrocodone: a randomised, double blind, placebo controlled trial

  Thorax · 2004 · 10.1136/thx.2003.019836

Current projects

No projects listed.